Get started
Author

Tim Everaert

Observed name: T. Everaert
ORCID: 0000-0002-6041-1042
Observed ORCID: 0000-0002-6041-1042
OpenAlex ID: A5064254451
Gantry triggered x-ray verification during single-isocenter stereotactic radiosurgery: Increased certainty for a no-margin strategy
2023 · Adrián Gutiérrez, Thierry Gevaert, et al. · Radiotherapy and Oncology · 7
PDF
Revisiting hydrogen peroxide as radiosensitizer for solid tumor cells
2024 · F. Geirnaert, L. Kerkhove, et al. · Radiotherapy and Oncology · 3
PDF
Exploring the role of hydrogen peroxide in the immune microenvironment of hypoxic tumors
2026 · Febe Geirnaert, Lisa Kerkhove, et al. · Clinical and Translational Radiation Oncology · 1
PDF
2371 Total neo-adjuvant treatment of locally advanced rectal cancer using short-course MRI-guided radiotherapy with simultaneous integrated boost.
2025 · Koen Kortbeek, Amy De Haar-Holleman, et al. · Radiotherapy and Oncology · 1
PD-0812 Validation of a high resolution solid state detector array for SBRT/SRS patient specific QA
2022 · J. Smeulders, T. Gevaert, et al. · Radiotherapy and Oncology · 1
Proseven trial: MR-guided prostate stereotactic body radiotherapy in seven days – First results
2025 · Benjamin Vanspeybroeck, Jacques Bezuidenhout, et al. · Radiotherapy and Oncology
1808 Phase II Study of MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days: toxicity analysis – preliminary results
2025 · Benjamin Vanspeybroeck, Jacques Bezuidenhout, et al. · Radiotherapy and Oncology
2741: Validation of 2D shifts for 3D motion in MR-guided radiotherapy of prostate cancer
2024 · Tim Everaert, Jacques Bodenstein Bezuidenhout, et al. · Radiotherapy and Oncology
2285: One year follow-up of total neoadjuvant treatment of rectal cancer by MRI-guided radiotherapy
2024 · Mark De Ridder, Jacques Bodenstein Bezuidenhout, et al. · Radiotherapy and Oncology
2372: Phase II Study of MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days: Toxicity Analysis
2024 · Jens van Loon, Jacques Bodenstein Bezuidenhout, et al. · Radiotherapy and Oncology
P-374 Total neoadjuvant treatment of rectal cancer by MRI-guided radiotherapy
2023 · M. De Ridder, J. Bezuidenhout, et al. · Annals of Oncology
PDF
PO-1871 Surface-guidance effectiveness in intracranial treatments with a closed immobilization mask
2023 · A. Gutierrez, K. Van Santvoort, et al. · Radiotherapy and Oncology
PO-1872 Assessment of setup errors and internal motion for rectal cancer using MR-guided radiotherapy
2023 · T. Everaert, A. Gutierrez Ruiz, et al. · Radiotherapy and Oncology
PO-1883 Markerless SBRT for lung treatment using ExacTrac Dynamic: a feasibility study
2023 · T. Gevaert, M. Boussaer, et al. · Radiotherapy and Oncology
PO-1599 The impact of dose calculation algorithms and beam modelling on delivery accuracy in MBM SRS
2021 · J. Smeulders, T. Gevaert, et al. · Radiotherapy and Oncology
PO-1715 Accuracy of a dedicated single isocenter stereotactic radiosurgery system for multiple brain lesions
2021 · T. Gevaert, A. Gutierrez, et al. · Radiotherapy and Oncology
Works count: 16
Citation count: 13
H-index: 2
I10-index:
Year
Topic
Type